中文 | English
Return
Total: 57 , 1/6
Show Home Prev Next End page: GO
Author:(Zixuan ZHAO)

1.Evaluation of Anti-osteoporosis Activity and Hepatotoxicity of Xianling Gubao Based on Zebrafish Model

Qiuman LI ; Yue QIAN ; Zixuan ZHU ; Yuan SONG ; Qian DENG ; Shengyun DAI ; Chongjun ZHAO

Chinese Journal of Experimental Traditional Medical Formulae 2025;31(4):87-94

2.Impacts of robot-assisted training on upper-limb function in stroke patients with hemiplegia:based on exploring with shear wave elastography

Rong XIE ; Zixuan GU ; Wenjun ZHAO

Chinese Journal of Rehabilitation Medicine 2025;40(11):1627-1636

3.The application of sequential analysis for continuous post-market vaccine safety surveillance

Zixuan LU ; Musu LI ; Jiahe PAN ; Yiwen WU ; Huilin LI ; Er YU ; Hongmei WO ; Shaowen TANG ; Yang ZHAO ; Juncheng DAI ; Honggang YI

Chinese Journal of Epidemiology 2025;46(3):514-518

4.Research status and future prospects of contact shielding for patients in diagnostic radiology

Dandan LIU ; Yongxian ZHANG ; Zixuan MA ; Yian LIU ; Tong ZHAO ; Tongxin ZHANG ; Hui XU ; Quanfu SUN ; Yantao NIU

Chinese Journal of Radiological Medicine and Protection 2025;45(9):934-940

5.Drug interaction of donepezil combined with moxifloxacin

Xuemei SUN ; Zhenying ZHAO ; Yuxi WANG ; Peipei CHEN ; Zixuan LI ; Min ZHANG ; Fei YU

Journal of China Medical University 2025;54(6):517-522

6.Effect of Lianpu Yin on Improvement of Duodenal Microinflammation in FD Rats and Its Mechanism via NLRP3 Activation

Yang ZHANG ; Wenliang LYU ; Shuhan ZHOU ; Ningfeng MAO ; Jiawei HE ; Yi ZHAO ; Zixuan XU ; Linlin LIU ; Xueyan WANG

World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(6):1693-1698

7.Application of the Bayesian mixture model based on a principal stra-tum strategy in clinical trials

Yiwen WU ; Yue SUN ; Zixuan LU ; Jiahe PAN ; Er YU ; Hongmei WO ; Shaowen TANG ; Yang ZHAO ; Juncheng DAI ; Honggang YI

Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(7):942-949

8.Comparison of the efficacy, safety, and cost-effectiveness of trastuzumab biosimilar HLX02 and the originator combined with pertuzumab and chemotherapy in the neoadjuvant treatment of patients with HER-2-positive breast cancer

Zixuan LEI ; Die SANG ; Bo LAN ; Ying FAN ; Ruigang CAI ; Yang LUO ; Qiao LI ; Jiayu WANG ; Longmei ZHAO ; Peng YUAN

Chinese Journal of Oncology 2025;47(6):517-524

9.The application of sequential analysis for continuous post-market vaccine safety surveillance

Zixuan LU ; Musu LI ; Jiahe PAN ; Yiwen WU ; Huilin LI ; Er YU ; Hongmei WO ; Shaowen TANG ; Yang ZHAO ; Juncheng DAI ; Honggang YI

Chinese Journal of Epidemiology 2025;46(3):514-518

10.Impacts of robot-assisted training on upper-limb function in stroke patients with hemiplegia:based on exploring with shear wave elastography

Rong XIE ; Zixuan GU ; Wenjun ZHAO

Chinese Journal of Rehabilitation Medicine 2025;40(11):1627-1636

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 57 , 1/6 Show Home Prev Next End page: GO